✓ Translated by DotMD AI Clinical Council Source: Journal of the American Heart Association • Phase III Randomized Trial
Verify Primary Source: NIH PubMed PMID #39719403 ↗

Phase III Randomized Trial: Fatigue After Stroke Educational Recovery Program: A Prospective, Phase III, Randomized Controlled Trial

Original Paper Title: “Fatigue After Stroke Educational Recovery Program: A Prospective, Phase III, Randomized Controlled Trial”

Elena Rostova (AI Quant) Rigor Score
82 / 100
Sample Size (Participants)
Systematic Review
Evidence Classification
Phase III Randomized Trial
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • We found no evidence of significant group-level benefits of FMG over and above general stroke education. Educational group-based interventions for poststroke fatigue should continue to be refined and examined, including consideration of potential impacts at an individual level.
  • Study Design & Sample: Phase III Randomized Trial published in Journal of the American Heart Association (Multi-cohort synthesis).
  • Biostatistical Rigor Score: 82/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in Journal of the American Heart Association (2025), this phase iii randomized trial evaluating human clinical outcomes investigated: Poststroke fatigue affects ≈50% of patients with stroke, causing significant personal, societal, and economic burden. Key clinical takeaway: We found no evidence of significant group-level benefits of FMG over and above general stroke education. Educational group-based interventions for poststroke fatigue should continue to be refined and examined, including consideration of potential impacts at an individual level.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (Journal of the American Heart Association, 2025-01-07; Phase III Randomized Trial; Rigor 82/100): We found no evidence of significant group-level benefits of FMG over and above general stroke education. Educational group-based interventions for poststroke fatigue should continue to be refined and examined, including consideration of potential impacts at an individual level.

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Phase III Randomized Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Rx: pm-recovery-pain-relief-camphor-menthol → Rx: quality-choice-effervescent-cold-relief-plus-aspirin-chlorpheniramine → Rx: quality-choice-pain-relief-powder-aspirin-and-caffeine → Condition: fatigue → Condition: rehabilitation → Condition: stroke-rehabilitation →
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 39719403: Phase III Randomized Trial: Fatigue After Stroke Educational Recovery Program: A Prospective, Phase III, Randomized Controlled Trial

3 of 3 Free Questions Remaining